Alendronate Osteoporosis Study

NCT00277251 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Glucocorticoid-Associated Osteopenia and Osteoporosis

Interventions

DRUG: Alendronate

Sponsor

Boston Children's Hospital

Collaborators

[object Object]
[object Object]